Empowering Scientific Breakthroughs: How Scientists Can Use AI and ML for Drug Discovery

In the rapidly evolving field of drug discovery, artificial intelligence (AI) and machine learning (ML) have become well-known multipliers in accelerating research and enhancing the development of therapeutic compounds.

This talk will explore Revvity Signals’ strategic journey and share details of existing AI/ML integrations into current Revvity Signals’ software solutions. The team will also discuss the future picture and direction of travel for AI/ML and their software solutions. The speakers will share their future direction and pipeline and explore how these solutions will continue to empower Scientists to drive significant breakthroughs in drug discovery.

They will share their insights into the opportunities afforded by AI/ML. Specifically, they will provide examples of how these tools are currently assisting researchers in their daily work in two ways: 1) to help Scientists document or efficiently use the software and 2) to help scientists accelerate their science.

They will also discuss about augmented intelligence, where AI and ML tools complement and enhance human expertise rather than replace it. The goal of augmented intelligence is to create solutions that support decision-making processes and accelerate routine tasks, allowing researchers to dedicate more time to higher-level analysis and creative problem-solving.

Register for this webinar today to discover how cutting-edge AI and ML technologies are being leveraged for drug discovery and development.

Speakers

Zev Wisotsky, Director of Drug Discovery Informatics, Revvity Signals

Zev Wisotsky is Director of Drug Discovery Informatics at Revvity Signals. His scientific training and research background includes neuroscience, biochemistry, molecular biology and drug discovery. He has spent more than eight years in software in go-to-market teams across industries with a heavy focus on biopharma/biotech R&D. 

Message Presenter

David Gosalvez, PhD, Executive Director, Strategy & Informatics Portfolio, Revvity Signals

With two decades of experience in scientific software, David Gosalvez brings a rare combination of technical and domain expertise with broad knowledge across scientific use cases. He is a passionate advocate for improving the efficiency and quality of science via innovative software solutions.

As Head of Product Strategy, David works with scientists and IT across pharma and chemical industry to set the direction of the Revvity Signals Informatics portfolio. He also works with other scientific software vendors to integrate complimentary capabilities into our solutions.

Read more...

As Director of Cheminformatics, he was responsible for the sustained growth of ChemDraw and Spotfire Lead Discovery. Previously, David headed the interdisciplinary Science & Technology team chartered with creating the novel data management technologies that underpinned Revvity Signals platform.

Read Less...

David also served as Executive Director of Application Development at CambridgeSoft where he brought to market the Oracle Chemistry Cartridge and ChemBioOffice Enterprise Suite.

Message Presenter